Pinnacle Health Center | |
1968 N Peart Rd Suite 1 Casa Grande AZ 85122-2495 | |
(520) 836-6636 | |
(520) 836-6846 |
Full Name | Pinnacle Health Center |
---|---|
Speciality | Clinic/Center |
Location | 1968 N Peart Rd, Casa Grande, Arizona |
Authorized Official Name and Position | Suresh V Balenalli (OWNER) |
Authorized Official Contact | 5202511067 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Pinnacle Health Center Po Box 13308 Chandler AZ 85248-0039 Ph: (520) 836-6636 | Pinnacle Health Center 1968 N Peart Rd Suite 1 Casa Grande AZ 85122-2495 Ph: (520) 836-6636 |
NPI Number | 1023152311 |
---|---|
Provider Enumeration Date | 02/19/2007 |
Last Update Date | 08/25/2014 |
Medicare PECOS PAC ID | 3476651449 |
---|---|
Medicare Enrollment ID | O20070614000569 |
News Archive
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.
Deaths of Americans age 18 and over hospitalized for pneumonia plummeted by 45 percent between 2000 and 2007 regardless of who paid for their care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers. Building on the recent clinical success of Mesoblast's proprietary cell product for expansion of cord blood, the Company will now address new markets where expansion of haematopoietic stem cells can make a meaningful impact on clinical outcomes, including diseases such as multiple myeloma.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1023152311 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | 28920 (Arizona) | Primary |
Provider Name | Suresh V Balenalli |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1336181437 PECOS PAC ID: 0941252159 Enrollment ID: I20050216000378 |
News Archive
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.
Deaths of Americans age 18 and over hospitalized for pneumonia plummeted by 45 percent between 2000 and 2007 regardless of who paid for their care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers. Building on the recent clinical success of Mesoblast's proprietary cell product for expansion of cord blood, the Company will now address new markets where expansion of haematopoietic stem cells can make a meaningful impact on clinical outcomes, including diseases such as multiple myeloma.
› Verified 7 days ago
News Archive
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.
A major social science study to accompany the Government's Bovine TB Badger Vaccine Deployment Project, to be launched this summer [2010], will be led by a researcher from the University of the West of England, with colleagues from the Countryside and Community Research Institute, in collaboration with Exeter and Cardiff Universities, Drew Associates Limited, the Veterinary Laboratories Agency and the Food and Environment Research Agency.
Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment.
Deaths of Americans age 18 and over hospitalized for pneumonia plummeted by 45 percent between 2000 and 2007 regardless of who paid for their care, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers. Building on the recent clinical success of Mesoblast's proprietary cell product for expansion of cord blood, the Company will now address new markets where expansion of haematopoietic stem cells can make a meaningful impact on clinical outcomes, including diseases such as multiple myeloma.
› Verified 7 days ago
Horizon Health And Wellness, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 W 2nd St, Casa Grande, AZ 85122 Phone: 520-836-3633 | |
Pinal Hispanic Council Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1667 N Trekell Rd Ste 101, Casa Grande, AZ 85122 Phone: 520-284-5436 Fax: 520-836-5436 | |
Center For Family Medicine Mdpc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 301 E Cottonwood Ln Ste 2, Casa Grande, AZ 85122 Phone: 520-426-1400 Fax: 520-426-1268 | |
Horizon Health And Wellness, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 115 W 2nd St, Casa Grande, AZ 85122 Phone: 520-836-1688 | |
Millennium Physician Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 E Mcmurray Blvd, Casa Grande, AZ 85122 Phone: 520-374-2090 | |
Regional Care Physicians Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1780 E Florence Blvd Ste 102, Casa Grande, AZ 85222 Phone: 520-381-6300 |